361 related articles for article (PubMed ID: 11978184)
1. Expression of p53, inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions: correlation with clinical features.
Feng CW; Wang LD; Jiao LH; Liu B; Zheng S; Xie XJ
BMC Cancer; 2002 Apr; 2():8. PubMed ID: 11978184
[TBL] [Abstract][Full Text] [Related]
2. Relationship between the expression of iNOS,VEGF,tumor angiogenesis and gastric cancer.
Song ZJ; Gong P; Wu YE
World J Gastroenterol; 2002 Aug; 8(4):591-5. PubMed ID: 12174362
[TBL] [Abstract][Full Text] [Related]
3. Correlations among Helicobacter pylori infection and the expression of cyclooxygenase-2 and vascular endothelial growth factor in gastric mucosa with intestinal metaplasia or dysplasia.
Liu D; He Q; Liu C
J Gastroenterol Hepatol; 2010 Apr; 25(4):795-9. PubMed ID: 20492336
[TBL] [Abstract][Full Text] [Related]
4. Expression of inducible nitric oxide synthase is significantly correlated with expression of vascular endothelial growth factor and dendritic cell infiltration in patients with advanced gastric carcinoma.
Yamaguchi K; Saito H; Oro S; Tatebe S; Ikeguchi M; Tsujitani S
Oncology; 2005; 68(4-6):471-8. PubMed ID: 16020977
[TBL] [Abstract][Full Text] [Related]
5. Inducible nitric oxide synthase expression is related to angiogenesis, bcl-2 and cell proliferation in hepatocellular carcinoma.
Peng JP; Zheng S; Xiao ZX; Zhang SZ
J Zhejiang Univ Sci; 2003; 4(2):221-7. PubMed ID: 12659238
[TBL] [Abstract][Full Text] [Related]
6. Significance of vascular endothelial growth factor expression and its correlation with inducible nitric oxide synthase in gastric cancer.
Song ZY; Wen SQ; Peng JP; Huang X; Qian KD
World J Gastroenterol; 2004 May; 10(9):1250-5. PubMed ID: 15112337
[TBL] [Abstract][Full Text] [Related]
7. Expression of ornithine decarboxylase in precancerous and cancerous gastric lesions.
Miao XP; Li JS; Li HY; Zeng SP; Zhao Y; Zeng JZ
World J Gastroenterol; 2007 May; 13(20):2867-71. PubMed ID: 17569126
[TBL] [Abstract][Full Text] [Related]
8. Expression of nitric oxide synthase in human gastric carcinoma and its relation to p53, PCNA.
Wang YZ; Cao YQ; Wu JN; Chen M; Cha XY
World J Gastroenterol; 2005 Jan; 11(1):46-50. PubMed ID: 15609395
[TBL] [Abstract][Full Text] [Related]
9. Inducible nitric oxide synthase expression in various laryngeal lesions in relation to carcinogenesis, angiogenesis, and patients' prognosis.
Shigyo H; Nonaka S; Katada A; Bandoh N; Ogino T; Katayama A; Takahara M; Hayashi T; Harabuchi Y
Acta Otolaryngol; 2007 Sep; 127(9):970-9. PubMed ID: 17712678
[TBL] [Abstract][Full Text] [Related]
10. Expression of p53 and vascular endothelial growth factor associated with tumor angiogenesis and prognosis in gastric cancer.
Maeda K; Kang SM; Onoda N; Ogawa M; Sawada T; Nakata B; Kato Y; Chung YS; Sowa M
Oncology; 1998; 55(6):594-9. PubMed ID: 9778629
[TBL] [Abstract][Full Text] [Related]
11. Angiogenic interactions of vascular endothelial growth factor, of thymidine phosphorylase, and of p53 protein expression in locally advanced gastric cancer.
Giatromanolaki A; Koukourakis MI; Stathopoulos GP; Kapsoritakis A; Paspatis G; Kakolyris S; Sivridis E; Georgoulias V; Harris AL; Gatter KC
Oncol Res; 2000; 12(1):33-41. PubMed ID: 11061344
[TBL] [Abstract][Full Text] [Related]
12. [Down-regulation of Caspase-3 expression in precancerous lesions and its relation to gastric carcinogenesis].
Yang L; Wu DY; Xin Y
Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):357-60. PubMed ID: 17045000
[TBL] [Abstract][Full Text] [Related]
13. Analysis of p53 expression in precancerous and malignant gastric mucosa.
Romiti A; Moretti A; Vecchione A; Muraro R; Feudi ML; Rinaldi V; Mancini R; Valli C; Mozzicafreddo A; Frati L; Tomao S
Oncol Rep; 1998; 5(1):109-13. PubMed ID: 9458303
[TBL] [Abstract][Full Text] [Related]
14. Coexpression of vascular endothelial growth factor and p53 protein in squamous cell carcinoma of the esophagus.
Koide N; Nishio A; Hiraguri M; Hanazaki K; Adachi W; Amano J
Am J Gastroenterol; 2001 Jun; 96(6):1733-40. PubMed ID: 11419822
[TBL] [Abstract][Full Text] [Related]
15. Expression of COX-2, iNOS, p53 and Ki-67 in gastric mucosa-associated lymphoid tissue lymphoma.
Li HL; Sun BZ; Ma FC
World J Gastroenterol; 2004 Jul; 10(13):1862-6. PubMed ID: 15222024
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical findings of nitric oxide synthase expression in urothelial transitional cell carcinoma including dysplasia.
Hayashi H; Kuwahara M; Fujisaki N; Furihata M; Ohtsuki Y; Kagawa S
Oncol Rep; 2001; 8(6):1275-9. PubMed ID: 11605048
[TBL] [Abstract][Full Text] [Related]
17. Changes in p53 and cyclin D1 protein levels and cell proliferation in different stages of human esophageal and gastric-cardia carcinogenesis.
Wang LD; Shi ST; Zhou Q; Goldstein S; Hong JY; Shao P; Qiu SL; Yang CS
Int J Cancer; 1994 Nov; 59(4):514-9. PubMed ID: 7960222
[TBL] [Abstract][Full Text] [Related]
18. PTEN encoding product: a marker for tumorigenesis and progression of gastric carcinoma.
Yang L; Kuang LG; Zheng HC; Li JY; Wu DY; Zhang SM; Xin Y
World J Gastroenterol; 2003 Jan; 9(1):35-9. PubMed ID: 12508347
[TBL] [Abstract][Full Text] [Related]
19. Changes of nitric oxide and growth factors during gastric ulcer healing.
Akimoto M; Hashimoto H; Shigemoto M; Yamashita K; Yokoyama I
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S282-5. PubMed ID: 11078399
[TBL] [Abstract][Full Text] [Related]
20. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]